![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: RGS5 |
Gene summary for RGS5 |
![]() |
Gene information | Species | Human | Gene symbol | RGS5 | Gene ID | 8490 |
Gene name | regulator of G protein signaling 5 | |
Gene Alias | MST092 | |
Cytomap | 1q23.3 | |
Gene Type | protein-coding | GO ID | GO:0007154 | UniProtAcc | O15539 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
8490 | RGS5 | P23T-E | Human | Esophagus | ESCC | 3.93e-02 | 1.85e+00 | 0.108 |
8490 | RGS5 | P94T-E | Human | Esophagus | ESCC | 1.64e-02 | 1.72e+00 | 0.0879 |
8490 | RGS5 | P104T-E | Human | Esophagus | ESCC | 4.20e-05 | 1.28e+00 | 0.0931 |
8490 | RGS5 | HCC1_Meng | Human | Liver | HCC | 2.12e-04 | -1.42e-01 | 0.0246 |
8490 | RGS5 | HCC5 | Human | Liver | HCC | 3.69e-09 | 5.00e-02 | 0.4932 |
8490 | RGS5 | Pt13.a | Human | Liver | HCC | 8.83e-19 | 7.26e-01 | 0.021 |
8490 | RGS5 | Pt13.b | Human | Liver | HCC | 7.93e-34 | 1.18e+00 | 0.0251 |
8490 | RGS5 | Pt13.c | Human | Liver | HCC | 2.01e-12 | 7.21e-01 | 0.0076 |
8490 | RGS5 | Pt14.b | Human | Liver | HCC | 7.51e-05 | 8.49e-01 | 0.018 |
8490 | RGS5 | Pt14.d | Human | Liver | HCC | 1.26e-19 | 6.62e-01 | 0.0143 |
8490 | RGS5 | C43 | Human | Oral cavity | OSCC | 1.43e-06 | -3.78e-01 | 0.1704 |
8490 | RGS5 | C46 | Human | Oral cavity | OSCC | 9.00e-05 | -3.77e-01 | 0.1673 |
8490 | RGS5 | C08 | Human | Oral cavity | OSCC | 8.31e-06 | -3.76e-01 | 0.1919 |
8490 | RGS5 | C09 | Human | Oral cavity | OSCC | 1.13e-02 | -3.73e-01 | 0.1431 |
8490 | RGS5 | NEOLP-2 | Human | Oral cavity | NEOLP | 1.13e-05 | 5.96e-01 | -0.0196 |
8490 | RGS5 | NEOLP-3 | Human | Oral cavity | NEOLP | 5.04e-04 | 5.73e-01 | -0.0191 |
8490 | RGS5 | SYSMH1 | Human | Oral cavity | OSCC | 1.90e-10 | -3.85e-01 | 0.1127 |
8490 | RGS5 | SYSMH2 | Human | Oral cavity | OSCC | 6.00e-07 | -3.77e-01 | 0.2326 |
8490 | RGS5 | SYSMH3 | Human | Oral cavity | OSCC | 9.03e-10 | -3.86e-01 | 0.2442 |
8490 | RGS5 | SYSMH4 | Human | Oral cavity | OSCC | 2.91e-07 | -3.85e-01 | 0.1226 |
Page: 1 2 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
RGS5 | SNV | Missense_Mutation | rs764215537 | c.368N>T | p.Thr123Met | p.T123M | O15539 | protein_coding | tolerated(0.27) | possibly_damaging(0.658) | TCGA-AJ-A3BG-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Chemotherapy | carboplatin | PD |
RGS5 | SNV | Missense_Mutation | c.467A>G | p.Asp156Gly | p.D156G | O15539 | protein_coding | deleterious(0) | probably_damaging(0.965) | TCGA-AP-A051-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
RGS5 | SNV | Missense_Mutation | c.35N>A | p.Cys12Tyr | p.C12Y | O15539 | protein_coding | deleterious(0.03) | benign(0.054) | TCGA-B5-A3FA-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
RGS5 | SNV | Missense_Mutation | c.482N>T | p.Arg161Ile | p.R161I | O15539 | protein_coding | deleterious(0) | possibly_damaging(0.902) | TCGA-BK-A6W3-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |
RGS5 | SNV | Missense_Mutation | c.35N>A | p.Cys12Tyr | p.C12Y | O15539 | protein_coding | deleterious(0.03) | benign(0.054) | TCGA-BS-A0UT-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |
RGS5 | SNV | Missense_Mutation | c.76N>A | p.Leu26Ile | p.L26I | O15539 | protein_coding | deleterious(0.04) | probably_damaging(0.994) | TCGA-BS-A0UV-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Unknown | Unknown | SD | |
RGS5 | SNV | Missense_Mutation | novel | c.370G>A | p.Glu124Lys | p.E124K | O15539 | protein_coding | deleterious(0.03) | possibly_damaging(0.788) | TCGA-DF-A2KN-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | Unknown | I/II | Unknown | Unknown | SD |
RGS5 | SNV | Missense_Mutation | novel | c.279N>A | p.Phe93Leu | p.F93L | O15539 | protein_coding | deleterious(0) | probably_damaging(0.997) | TCGA-EO-A22U-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
RGS5 | SNV | Missense_Mutation | c.509N>A | p.Ser170Tyr | p.S170Y | O15539 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-EO-A3AV-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | carboplatin | CR | |
RGS5 | SNV | Missense_Mutation | novel | c.507N>G | p.Asp169Glu | p.D169E | O15539 | protein_coding | deleterious(0) | probably_damaging(0.995) | TCGA-EO-A3B0-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Unknown | Unknown | SD |
Page: 1 2 3 4 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
8490 | RGS5 | NA | irinotecan | IRINOTECAN | 25069475 | |
8490 | RGS5 | NA | bevacizumab | BEVACIZUMAB | 25069475 | |
8490 | RGS5 | NA | fluorouracil | FLUOROURACIL | 25069475 | |
8490 | RGS5 | NA | leucovorin | LEUCOVORIN | 25069475 |
Page: 1 |